Evidence for the distinct vanadyl(+4)-dependent activating system for manifesting insulin-like effects

Biochemistry. 1996 Jun 25;35(25):8314-8. doi: 10.1021/bi960209i.

Abstract

Both exogenously added vanadate (oxidation state +5) and vanadyl (oxidation state +4) mimic the rapid responses of insulin through alternative signaling pathways, not involving insulin receptor activation [reviewed in Shechter et al. (1995) Mol. Cell. Biochem. 153, 39-47]. Vanadium exhibits complex chemistry, fluctuating between vanadate(+5) and vanadyl(+4), according to the prevailing conditions. Using several experimental approaches, we report here on a distinct vanadate(+5)-independent, vanadyl(+4)-dependent activating pathway. The key components of this pathway are membrane protein phosphotyrosine phosphatases (PTPases) and a cytosolic (nonreceptor) protein-tyrosine kinase (CytPTK). We further suggest that vanadate(+5) is not reduced rapidly to vanadyl(+4) inside the cell, and entered vanadyl sulfate(+4) is capable of undergoing spontaneous oxidation to vanadate(+5) in vivo. Finally, we show that the promotion and full expression of a downstream bioeffect such as lipogenesis requires both activation of CytPTK and prolonged stability of vanadyl(+4) against oxidation.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipocytes / drug effects*
  • Animals
  • Cytosol / enzymology
  • Dose-Response Relationship, Drug
  • Enzyme Activation
  • Glutathione / pharmacology
  • Hypoglycemic Agents / pharmacology
  • Insulin / pharmacology*
  • Lipids / biosynthesis
  • Male
  • Molecular Mimicry
  • Oxidation-Reduction
  • Protein-Tyrosine Kinases / metabolism
  • Rats
  • Rats, Wistar
  • Signal Transduction
  • Vanadium Compounds / pharmacology*

Substances

  • Hypoglycemic Agents
  • Insulin
  • Lipids
  • Vanadium Compounds
  • vanadyl sulfate
  • Protein-Tyrosine Kinases
  • Glutathione